Chemical Formula: C15H17N3O2S

Chemical Formula C15H17N3O2S

Found 11 metabolite its formula value is C15H17N3O2S

N-{[4-methoxy-5-(methylsulfanyl)-[2,2'-bipyridine]-6-yl]methyl}ethanimidate

N-[(4-methoxy-3-methylsulfanyl-6-pyridin-2-ylpyridin-2-yl)methyl]acetamide

C15H17N3O2S (303.1041)


Based on the SMILES structure ​CC(=O)NCC1=C(C(=CC(=N1)C2=CC=CC=N2)OC)SC, the compound likely contains a ​thiazole ring (due to sulfur and nitrogen in the 5-membered ring) fused with a ​pyridine ring (6-membered aromatic ring with nitrogen), along with an ​acetyl group and a ​methoxy substituent. Here’s a speculative analysis of its potential biological functions: ​Antimicrobial Activity The thiazole-pyridine core is structurally similar to certain ​antibiotics (e.g., sulfathiazole derivatives) and ​antifungal agents. Thiazoles are known to disrupt bacterial cell wall synthesis or inhibit enzymes like dihydrofolate reductase (DHFR), critical for microbial survival. ​Kinase or Enzyme Inhibition The pyridine-thiazole system resembles scaffolds in ​tyrosine kinase inhibitors (e.g., dasatinib analogs) used in cancer therapy. The acetyl group may enhance solubility or act as a prodrug moiety, while the methoxy group could modulate binding to hydrophobic enzyme pockets. ​Anti-inflammatory or Analgesic Effects Acetamide derivatives (e.g., paracetamol analogs) often exhibit pain-relieving properties. The sulfur atom might contribute to antioxidant activity, potentially mitigating oxidative stress in inflammatory pathways. ​Neuroactive Potential Pyridine-thiazole hybrids are explored in ​neurological disorders (e.g., acetylcholinesterase inhibitors for Alzheimer’s). The structure’s aromaticity and polar groups may facilitate blood-brain barrier penetration. Key Rationale: The compound’s hybrid heterocyclic system (thiazole + pyridine) and substituents (acetyl, methoxy) align with pharmacophores for targeting proteins, nucleic acids, or microbial enzymes. Experimental validation (e.g., enzyme assays, microbial screens) would be needed to confirm specific activities.

   

4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzoic acid

4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzoic acid

C15H17N3O2S (303.1041)


   

3-BENZYL-1-ISOPROPYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOTHIOAMIDE

3-BENZYL-1-ISOPROPYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOTHIOAMIDE

C15H17N3O2S (303.1041)


   

Celecoxib iMpurity-G

Celecoxib iMpurity-G

C15H17N3O2S (303.1041)


   

ETHYL 4-(BENZYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLATE

ETHYL 4-(BENZYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLATE

C15H17N3O2S (303.1041)


   

Pumosetrag

Pumosetrag

C15H17N3O2S (303.1041)


C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

   

1-(4-Methoxyphenyl)-3-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)urea

1-(4-Methoxyphenyl)-3-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)urea

C15H17N3O2S (303.1041)


   

2-[[6-(2-Furanyl)-3-pyridazinyl]thio]-1-(1-piperidinyl)ethanone

2-[[6-(2-Furanyl)-3-pyridazinyl]thio]-1-(1-piperidinyl)ethanone

C15H17N3O2S (303.1041)


   

1-(4-methoxyphenyl)-N-(1,3,4-thiadiazol-2-yl)-1-cyclopentanecarboxamide

1-(4-methoxyphenyl)-N-(1,3,4-thiadiazol-2-yl)-1-cyclopentanecarboxamide

C15H17N3O2S (303.1041)


   

n-{[4-methoxy-5-(methylsulfanyl)-[2,2'-bipyridin]-6-yl]methyl}ethanimidic acid

n-{[4-methoxy-5-(methylsulfanyl)-[2,2'-bipyridin]-6-yl]methyl}ethanimidic acid

C15H17N3O2S (303.1041)


   

N-(2,3-dimethylphenyl)-2-[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)sulfanyl]acetamide

N-(2,3-dimethylphenyl)-2-[(4-methyl-6-oxo-1H-pyrimidin-2-yl)sulfanyl]acetamide

C15H17N3O2S (303.1041)